- Japan（Japanese / English）
- Global
- MBL TOP
- MBL site search
Close
The price is only for customers living in Japan.
For customer living outside of Japan, please visit the Global page.
For customer living outside of Japan, please visit the Global page.
HOME > Product search results
Product
[-] MHC tetramer（475）
>Class I（475）
Refine your search
[+]Animal species
[+]Category
[+]Conjugate
[+]MHC Allele
[+]Research area
[+]Tools
[+]Brands
[+]Availability (in Japan)
MHC tetramer（475）
| Clip | Code No. | Product | Data | ||||
|---|---|---|---|---|---|---|---|
| Data
Sheet |
Category | Conjugate | MHC Allele | Size | Price | Availability | |
| Sequence | Location (aa) | Storage
temp. |
|||||
|
|
|||||||
|
TC-0119-4 |
HLA-B*07:02 Tyrosinase Tetramer-LPWHRLFLL-BV421 |
|
||||
|
cancer | BV421 | B*07:02 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| LPWHRLFLL | 208-216 | ４°C | |||||
|
|
TC-0166-4 |
HLA-A*03:01 gp100 Tetramer-ALLAVGATK-BV421 |
|
||||
|
|
cancer | BV421 | A*03:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| ALLAVGATK | ４°C | ||||||
|
|
TS-M105-4 |
HLA-A*02:01 NY-ESO-1 C9V Tetramer-SLLMWITQV-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 | 1-9 | |
| SLLMWITQV | 157-165 | ４°C | |||||
|
|
TC-0156-1 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| QLCPICRAPV | 175-184 | ４°C | |||||
|
|
TS-0017-2 |
HLA-A*02:01 PR-1 Tetramer-VLQELNVTV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| VLQELNVTV | 169-177 | ４°C | |||||
|
|
TC-0105-1 |
HLA-A*03:01 hTERT Tetramer-KLFGVLRLK-PE |
|
||||
|
|
cancer | PE | A*03:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| KLFGVLRLK | ４°C | ||||||
|
|
TC-0136-1 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| GLAPPQHLIRV | 187-197 | ４°C | |||||
|
|
TS-M107-4 |
HLA-A*02:01 PAP 299-307 Tetramer-ALDVYNGLL-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| ALDVYNGLL | 299-307 | ４°C | |||||
|
|
TC-0105-2 |
HLA-A*03:01 hTERT Tetramer-KLFGVLRLK-APC |
|
||||
|
|
cancer | APC | A*03:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| KLFGVLRLK | ４°C | ||||||
|
|
TC-0164-1 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| YMCSFLFNL | 666-674 | ４°C | |||||
|
|
TC-0136-4 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| GLAPPQHLIRV | 187-197 | ４°C | |||||
|
|
TC-0108-2 |
HLA-A*03:01 Survivin 18-27 (modK) Tetramer-RISTFKNWPK-APC |
|
||||
|
|
cancer | APC | A*03:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| RISTFKNWPK | ４°C | ||||||
|
|
TC-0112-4 |
HLA-A*02:01 Mesothelin Tetramer-VLPLTVAEV-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| VLPLTVAEV | ４°C | ||||||
|
|
TC-0113-1 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| YLFFYRKSV | ４°C | ||||||
|
|
TC-0119-2 |
HLA-B*07:02 Tyrosinase Tetramer-LPWHRLFLL-APC |
|
||||
|
|
cancer | APC | B*07:02 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| LPWHRLFLL | 208-216 | ４°C | |||||
|
|
TC-0157-1 |
HLA-A*02:01 p53 Tetramer-RMPEAAPPV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| RMPEAAPPV | 65-73 | ４°C | |||||
|
|
TC-0161-1 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| VLAGGFFLL | 27-38 | ４°C | |||||
|
|
TS-0016-4 |
HLA-A*02:01 Her-2/neu Tetramer-RLLQETELV-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| RLLQETELV | 689-697 | ４°C | |||||
|
|
TC-0150-4 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| GLLGASVLGL | 674-683 | ４°C | |||||
|
|
TC-0163-1 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| YLGSYGFRL | 103-111 | ４°C | |||||
|
|
TS-0017-1 |
HLA-A*02:01 PR-1 Tetramer-VLQELNVTV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| VLQELNVTV | 169-177 | ４°C | |||||
|
|
TS-M070-2 |
HLA-A*02:01 MAGE-A1 Tetramer-KVLEYVIKV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| KVLEYVIKV | 278-286 | ４°C | |||||
|
|
TC-0126-2 |
HLA-A*01:01 Tyrosinase Tetramer-KSDICTDEY-APC |
|
||||
|
|
cancer | APC | A*01:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| KSDICTDEY | 243-251 | ４°C | |||||
|
|
TC-0127-1 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| AILALLPAL | 105-133 | ４°C | |||||
|
|
TC-0127-4 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| AILALLPAL | 105-133 | ４°C | |||||
|
|
TC-0128-1 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| ALLTSRLRFI | 615-624 | ４°C | |||||
|
|
TC-0157-4 |
HLA-A*02:01 p53 Tetramer-RMPEAAPPV-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| RMPEAAPPV | 65-73 | ４°C | |||||
|
|
TC-0161-2 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| VLAGGFFLL | 27-38 | ４°C | |||||
|
|
TC-0163-2 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| YLGSYGFRL | 103-111 | ４°C | |||||
|
|
TS-M072-2 |
HLA-A*02:01 MAGE-A2 Tetramer-YLQLVFGIEV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| YLQLVFGIEV | 157-166 | ４°C | |||||
|
|
TC-0120-1 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| YLEPGPVTV | ４°C | ||||||
|
|
TC-0132-4 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| FLYDDNQRV | 828-836 | ４°C | |||||
|
|
TC-0152-2 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| KLCPVQLWV | 139-147 | ４°C | |||||
|
|
TC-0169-1 |
HLA-A*02:01 BCR-ABL Tetramer-GVRGRVEEI-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| GVRGRVEEI | ４°C | ||||||
|
|
TS-M070-4 |
HLA-A*02:01 MAGE-A1 Tetramer-KVLEYVIKV-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| KVLEYVIKV | 278-286 | ４°C | |||||
|
|
TS-M076-2 |
HLA-A*02:01 MAGE-A3 271-279 Tetramer-FLWGPRALV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 | 1-9 | |
| FLWGPRALV | 271-279 | ４°C | |||||
|
|
TC-0114-4 |
HLA-A*02:01 hTERT Tetramer-YLQVNSLQTV-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| YLQVNSLQTV | ４°C | ||||||
|
|
TC-0151-1 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| GLQHWVPEL | 97-106 | ４°C | |||||
|
|
TC-0158-2 |
HLA-A*02:01 CD20 Tetramer-SLFLGILSV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| SLFLGILSV | 188-196 | ４°C | |||||
|
|
TC-0164-2 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| YMCSFLFNL | 666-674 | ４°C | |||||
|
|
TC-0110-1 |
HLA-A*02:01 Mesothelin Tetramer-SLLFLLFSL-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 | 1-9 | |
| SLLFLLFSL | ４°C | ||||||
|
|
TC-0110-4 |
HLA-A*02:01 Mesothelin Tetramer-SLLFLLFSL-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| SLLFLLFSL | ４°C | ||||||
|
|
TC-0152-4 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| KLCPVQLWV | 139-147 | ４°C | |||||
|
|
TC-0159-1 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| SLPPPGTRV | 149-157 | ４°C | |||||
|
|
TS-M120-4 |
HLA-A*02:01 PSA 141-150 Tetramer-FLTPKKLQCV-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| FLTPKKLQCV | 141-150 | ４°C | |||||
|
|
TS-M082-2 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTA-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| YLEPGPVTA | 280-288 | ４°C | |||||
|
|
TC-0114-1 |
HLA-A*02:01 hTERT Tetramer-YLQVNSLQTV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| YLQVNSLQTV | ４°C | ||||||
|
|
TC-0132-1 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| FLYDDNQRV | 828-836 | ４°C | |||||
|
|
TC-0136-2 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| GLAPPQHLIRV | 187-197 | ４°C | |||||
|
|
TC-0156-2 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| QLCPICRAPV | 175-184 | ４°C | |||||
|
|
TS-M016-4 |
HLA-A*02:01 WT1126-134 Tetramer-RMFPNAPYL-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| RMFPNAPYL | 126-134 | ４°C | |||||
|
|
TS-M115-4 |
HLA-A*02:01 hTERT Tetramer-ILAKFLHWL-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| ILAKFLHWL | ４°C | ||||||
|
|
TC-0120-4 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| YLEPGPVTV | ４°C | ||||||
|
|
TC-0151-4 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| GLQHWVPEL | 97-106 | ４°C | |||||
|
|
TC-0163-4 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| YLGSYGFRL | 103-111 | ４°C | |||||
|
|
TC-0120-2 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| YLEPGPVTV | ４°C | ||||||
|
|
TC-0128-2 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| ALLTSRLRFI | 615-624 | ４°C | |||||
|
|
TC-0153-4 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| LLLTVLTVV | 13-21 | ４°C | |||||
|
|
TS-M078-4 |
HLA-A*02:01 MAGE-A10 Tetramer-GLYDGMEHL-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| GLYDGMEHL | ４°C | ||||||
|
|
TS-0016-2 |
HLA-A*02:01 Her-2/neu Tetramer-RLLQETELV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| RLLQETELV | 689-697 | ４°C | |||||
|
|
TC-0112-1 |
HLA-A*02:01 Mesothelin Tetramer-VLPLTVAEV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| VLPLTVAEV | ４°C | ||||||
|
|
TC-0127-2 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| AILALLPAL | 105-133 | ４°C | |||||
|
|
TS-M088-4 |
HLA-A*02:01 MUC1 Tetramer-LLLLTVLTV-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| LLLLTVLTV | 12-20 | ４°C | |||||
|
|
TC-0150-1 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| GLLGASVLGL | 674-683 | ４°C | |||||
|
|
TC-0153-2 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| LLLTVLTVV | 13-21 | ４°C | |||||
|
|
TS-M082-4 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTA-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| YLEPGPVTA | 280-288 | ４°C | |||||
|
|
TC-0112-2 |
HLA-A*02:01 Mesothelin Tetramer-VLPLTVAEV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| VLPLTVAEV | ４°C | ||||||
|
|
TC-0114-2 |
HLA-A*02:01 hTERT Tetramer-YLQVNSLQTV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| YLQVNSLQTV | ４°C | ||||||
|
|
TC-0159-2 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| SLPPPGTRV | 149-157 | ４°C | |||||
|
|
TC-0110-2 |
HLA-A*02:01 Mesothelin Tetramer-SLLFLLFSL-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| SLLFLLFSL | ４°C | ||||||
|
|
TC-0169-4 |
HLA-A*02:01 BCR-ABL Tetramer-GVRGRVEEI-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| GVRGRVEEI | ４°C | ||||||
|
|
TC-0128-4 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| ALLTSRLRFI | 615-624 | ４°C | |||||
|
|
TS-M076-4 |
HLA-A*02:01 MAGE-A3 271-279 Tetramer-FLWGPRALV-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| FLWGPRALV | 271-279 | ４°C | |||||
|
|
TC-0113-4 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| YLFFYRKSV | ４°C | ||||||
|
|
TC-0132-2 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| FLYDDNQRV | 828-836 | ４°C | |||||
|
|
TC-0164-4 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| YMCSFLFNL | 666-674 | ４°C | |||||
|
|
TC-0113-2 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| YLFFYRKSV | ４°C | ||||||
|
|
TC-0150-2 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| GLLGASVLGL | 674-683 | ４°C | |||||
|
|
TC-0152-1 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| KLCPVQLWV | 139-147 | ４°C | |||||
|
|
TC-0161-4 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| VLAGGFFLL | 27-38 | ４°C | |||||
|
|
TS-M072-4 |
HLA-A*02:01 MAGE-A2 Tetramer-YLQLVFGIEV-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| YLQLVFGIEV | 157-166 | ４°C | |||||
|
|
TC-8006-1 |
HLA-A*02:01 P53168-176 R175H Tetramer-HMTEVVRHC-PE
|
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| HMTEVVRHC | 168-176 | ４°C | |||||
|
|
TC-8032-1 |
HLA-A*03:01 KRAS7-16 G12V Tetramer-VVVGAVGVGK-PE
|
|
||||
|
|
cancer | PE | A*03:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| VVVGAVGVGK | 7-16 | ４°C | |||||
|
|
TC-8026-2 |
HLA-A*24:02 NY-ESO-1158-166 Tetramer-LLMWITQCF-APC
|
|
||||
|
|
cancer | APC | A*24:02 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| LLMWITQCF | 158-166 | ４°C | |||||
|
|
TC-8006-2 |
HLA-A*02:01 P53168-176 R175H Tetramer-HMTEVVRHC-APC
|
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| HMTEVVRHC | 168-176 | ４°C | |||||
|
|
TC-8031-1 |
HLA-A*03:01 KRAS7-16 G12D Tetramer-VVVGADGVGK-PE
|
|
||||
|
|
cancer | PE | A*03:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| VVVGADGVGK | 7-16 | ４°C | |||||
|
|
TS-M243-1 |
HLA-A*02:01 UGCGL2 Neoepitope Tetramer-GLLDEDFYA-PE
|
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| GLLDEDFYA | ４°C | ||||||
|
|
TS-M271-2 |
HLA-B*07:02 GNB5 Neoepitope Tetramer-RVSTLRVSL-APC
|
|
||||
|
|
cancer | APC | B*07:02 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| RVSTLRVSL | ４°C | ||||||
|
|
TS-M610-1 |
H-2Kb SGK1 Tetramer-STLTYSRM-PE
|
|
||||
|
|
cancer | PE | H-2Kb | 50 tests | ￥209,000 |
0 (Contact us) |
|
| STLTYSRM | 10-17 | ４°C | |||||
|
|
TS-M251-1 |
HLA-A*03:01 SIRT2 Neoepitope Tetramer-KIFSEVTLK-PE
|
|
||||
|
|
cancer | PE | A*03:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| KIFSEVTLK | ４°C | ||||||
|
|
TC-8029-1 |
HLA-A*03:01 KRAS8-16 G12C Tetramer-VVGACGVGK-PE
|
|
||||
|
|
cancer | PE | A*03:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| VVGACGVGK | 8-16 | ４°C | |||||
|
|
TC-8023-2 |
HLA-A*11:01 KRAS7-16 G12S Tetramer- VVVGASGVGK-APC
|
|
||||
|
|
cancer | APC | A*11:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| VVVGASGVGK | 7-16 | ４°C | |||||
|
|
TC-8001-1 |
HLA-A*11:01 KRAS7-16 G12D Tetramer-VVVGADGVGK-PE
|
|
||||
|
|
cancer | PE | A*11:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| VVVGADGVGK | 7-16 | ４°C | |||||
|
|
TS-M255-2 |
HLA-A*03:01 ATR Neoepitope Tetramer-KLYEEPLLK-APC
|
|
||||
|
|
cancer | APC | A*03:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| KLYEEPLLK | ４°C | ||||||
|
|
TS-M272-1 |
HLA-B*07:02 MLL3 Neoepitope Tetramer-KPSDTPRPVM-PE
|
|
||||
|
|
cancer | PE | B*07:02 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| KPSDTPRPVM | ４°C | ||||||
|
|
TS-M271-1 |
HLA-B*07:02 GNB5 Neoepitope Tetramer-RVSTLRVSL-PE
|
|
||||
|
|
cancer | PE | B*07:02 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| RVSTLRVSL | ４°C | ||||||
|
|
TS-M255-1 |
HLA-A*03:01 ATR Neoepitope Tetramer-KLYEEPLLK-PE
|
|
||||
|
|
cancer | PE | A*03:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| KLYEEPLLK | ４°C | ||||||
|
|
TS-M252-1 |
HLA-A*03:01 PRPF6 Neoepitope Tetramer-KILDAVVAQK-PE
|
|
||||
|
|
cancer | PE | A*03:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| KILDAVVAQK | ４°C | ||||||
|
|
TS-M246-1 |
HLA-A*02:01 GOLGA3 Neoepitope Tetramer-SLDLTTSPV-PE
|
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| SLDLTTSPV | ４°C | ||||||
|
|
TS-M202-1 |
HLA-A*01:01 NRAS Neoepitope Tetramer-ILDTAGREEY-PE
|
|
||||
|
|
cancer | PE | A*01:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| ILDTAGREEY | ４°C | ||||||
- The availability is based on the information in Japan at 17:01, Feb 9, 2026 in JST.
- The special price is shown in red color.
- Please note that products cannot be ordered from this website. To purchase the items listed in this website, please contact us or local distributers.
- For storage temparature: RT: room temparature
- Please note that products in this website might be changed or discontinued without notification in advance for quality improvement.